share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  10/11 14:04

Moomoo AI 已提取核心訊息

Pfizer Inc. (PFE) has reported a significant transaction involving its Chairman & CEO, Albert Bourla. According to the announcement, the transaction took place on October 10, 2024. However, the details regarding the number of shares, the nature of the shares, the transaction price, and the total value of the shares involved in the transaction were not disclosed. The report also did not specify the number of shares held by Bourla after the transaction. This information is crucial for investors to understand the potential impact of the transaction on their holdings and the market's perception of Pfizer's stock.
Pfizer Inc. (PFE) has reported a significant transaction involving its Chairman & CEO, Albert Bourla. According to the announcement, the transaction took place on October 10, 2024. However, the details regarding the number of shares, the nature of the shares, the transaction price, and the total value of the shares involved in the transaction were not disclosed. The report also did not specify the number of shares held by Bourla after the transaction. This information is crucial for investors to understand the potential impact of the transaction on their holdings and the market's perception of Pfizer's stock.
輝瑞公司(PFE)報告了一項涉及其董事長兼首席執行官Albert Bourla的重大交易。根據公告,交易發生在2024年10月10日。然而,關於交易涉及的股份數量、股份性質、交易價格以及交易涉及的股票總價值的具體細節並未披露。報告還未指明Bourla在交易後持有的股份數量。這些信息對於投資者了解交易對其持股的潛在影響以及市場對輝瑞股票的看法至關重要。
輝瑞公司(PFE)報告了一項涉及其董事長兼首席執行官Albert Bourla的重大交易。根據公告,交易發生在2024年10月10日。然而,關於交易涉及的股份數量、股份性質、交易價格以及交易涉及的股票總價值的具體細節並未披露。報告還未指明Bourla在交易後持有的股份數量。這些信息對於投資者了解交易對其持股的潛在影響以及市場對輝瑞股票的看法至關重要。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息